{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:02Z","timestamp":1793059982367,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.eprac.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T13:42:03Z","timestamp":1609422123000},"page":"312-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Association Between Prolactinoma and Body Mass Index"],"prefix":"10.1016","volume":"27","author":[{"given":"Farah","family":"Al Sabie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunera","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Donegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2020.09.001_bib1","unstructured":"Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018."},{"key":"10.1016\/j.eprac.2020.09.001_bib2","doi-asserted-by":"crossref","first-page":"i2156","DOI":"10.1136\/bmj.i2156","article-title":"BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants","volume":"353","author":"Aune","year":"2016","journal-title":"BMJ"},{"issue":"39","key":"10.1016\/j.eprac.2020.09.001_bib3","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.15585\/mmwr.mm6639e1","article-title":"Vital signs: trends and incidence of cancers associated with overweight and obesity - United States, 2005-2014","volume":"66","author":"Steele","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.eprac.2020.09.001_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000115367","article-title":"Classical endocrine diseases causing obesity","volume":"36","author":"Weaver","year":"2008","journal-title":"Front Horm Res"},{"issue":"5","key":"10.1016\/j.eprac.2020.09.001_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2265.1998.00403.x","article-title":"Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels","volume":"48","author":"Greenman","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.eprac.2020.09.001_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13098-015-0094-4","article-title":"Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline","volume":"7","author":"Pala","year":"2015","journal-title":"Diabetol Metab Syndr"},{"issue":"5","key":"10.1016\/j.eprac.2020.09.001_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.eprac.2020.09.001_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/07435800.2015.1135444","article-title":"Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-S and growth hormone be the missing link?","volume":"41","author":"Peric","year":"2016","journal-title":"Endocr Res"},{"issue":"4","key":"10.1016\/j.eprac.2020.09.001_bib9","first-page":"392","article-title":"Prolactinoma and body weight: a retrospective study","volume":"125","author":"Creemers","year":"1991","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1","key":"10.1016\/j.eprac.2020.09.001_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/eje.0.1470077","article-title":"Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine","volume":"147","author":"Doknic","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2020.09.001_bib11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/oby.2010.150","article-title":"BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists","volume":"19","author":"dos Santos Silva","year":"2011","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.eprac.2020.09.001_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/cen.12204","article-title":"Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels","volume":"79","author":"Ciresi","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.eprac.2020.09.001_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0361-9230(86)90226-1","article-title":"Hyperprolactinemia stimulates food intake in the female rat","volume":"17","author":"Moore","year":"1986","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.1016\/j.eprac.2020.09.001_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0031-9384(93)90057-M","article-title":"Effects of systemic and central prolactin injections on food intake, weight gain, and estrous cyclicity in female rats","volume":"54","author":"Noel","year":"1993","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1016\/j.eprac.2020.09.001_bib15","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1096\/fj.201902357R","article-title":"Chronic high prolactin levels impact on gene expression at discrete hypothalamic nuclei involved in food intake","volume":"34","author":"Lopez-Vicchi","year":"2020","journal-title":"Faseb J"},{"issue":"12","key":"10.1016\/j.eprac.2020.09.001_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5152\/jtgga.2015.15015","article-title":"Hyperprolactinemia has no effect on plasma ghrelin levels in patients with prolactinoma","volume":"16","author":"Delibasi","year":"2015","journal-title":"J\u00a0Turk Ger Gynecol Assoc"},{"issue":"6","key":"10.1016\/j.eprac.2020.09.001_bib17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1530\/EJE-14-0990","article-title":"Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth","volume":"172","author":"Delgrange","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2020.09.001_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/eje.0.1480325","article-title":"Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia","volume":"148","author":"Colao","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2020.09.001_bib19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s12020-013-9931-0","article-title":"Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemia","volume":"44","author":"Atmaca","year":"2013","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.eprac.2020.09.001_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-2265.2007.02973.x","article-title":"Body fat in nonobese women with prolactinoma treated with dopamine agonists","volume":"67","author":"Naliato","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2020.09.001_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/oby.2003.46","article-title":"Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia","volume":"11","author":"Korner","year":"2003","journal-title":"Obes Res"},{"issue":"1","key":"10.1016\/j.eprac.2020.09.001_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11011-016-9882-2","article-title":"Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas","volume":"32","author":"Schwetz","year":"2017","journal-title":"Metab Brain Dis"},{"issue":"10","key":"10.1016\/j.eprac.2020.09.001_bib23","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1530\/EC-19-0286","article-title":"Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysis","volume":"8","author":"Byberg","year":"2019","journal-title":"Endocr Connect"},{"issue":"3","key":"10.1016\/j.eprac.2020.09.001_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2000-8451","article-title":"Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones","volume":"33","author":"Baptista","year":"2000","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.eprac.2020.09.001_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diacare.19.6.667","article-title":"Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects","volume":"19","author":"Cincotta","year":"1996","journal-title":"Diabetes Care"},{"issue":"1516","key":"10.1016\/j.eprac.2020.09.001_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4414\/smw.2006.10955","article-title":"Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma","volume":"136","author":"Schmid","year":"2006","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"10.1016\/j.eprac.2020.09.001_bib27","first-page":"12","article-title":"Body fat distribution, the menopause transition, and hormone replacement therapy","volume":"26","author":"Tchernof","year":"2000","journal-title":"Diabetes Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20483570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20483570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:09:38Z","timestamp":1761516578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20483570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1530891X20483570"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2020.09.001","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Prolactinoma and Body Mass Index","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}